{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:29:38Z","timestamp":1793636978052,"version":"4.5.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013323","name":"Yancheng Science and Technology Bureau","doi-asserted-by":"publisher","award":["YCBK2026195"],"award-info":[{"award-number":["YCBK2026195"]}],"id":[{"id":"10.13039\/501100013323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neo.2026.101378","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:30:20Z","timestamp":1792510220000},"page":"101378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Ubiquitin-specific proteases and the immune microenvironment in cervical cancer: mechanistic evidence, immunotherapy resistance, and therapeutic perspectives"],"prefix":"10.1016","volume":"82","author":[{"given":"Yanhua","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liling","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weipei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyou","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neo.2026.101378_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.neo.2026.101378_bib0002","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"issue":"20","key":"10.1016\/j.neo.2026.101378_bib0003","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"17","key":"10.1016\/j.neo.2026.101378_bib0004","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1200\/JCO.18.01265","article-title":"Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer: results from the phase II KEYNOTE-158 study","volume":"37","author":"Chung","year":"2019","journal-title":"J. Clinic. Oncol."},{"issue":"10","key":"10.1016\/j.neo.2026.101378_bib0005","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S1470-2045(23)00411-4","article-title":"Safety and antitumour activity of cadonilimab, an anti-PD-1\/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b\/2 trial","volume":"24","author":"Gao","year":"2023","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.neo.2026.101378_bib0006","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1200\/JCO.21.02067","article-title":"Dual PD-1 and CTLA-4 checkpoint blockade using balstilimab and zalifrelimab combination as second-line treatment for advanced cervical cancer: an open-label phase II study","volume":"40","author":"O'Malley","year":"2022","journal-title":"J. Clinic. Oncol."},{"issue":"7637","key":"10.1016\/j.neo.2026.101378_bib0007","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nature21349","article-title":"Elements of cancer immunity and the cancer-immune set point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"issue":"7681","key":"10.1016\/j.neo.2026.101378_bib0008","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature24473","article-title":"A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy","volume":"551","author":"Luksza","year":"2017","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.neo.2026.101378_bib0009","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrm2731","article-title":"Breaking the chains: structure and function of the deubiquitinases","volume":"10","author":"Komander","year":"2009","journal-title":"Nat. Rev. Molecul. Cell Biol."},{"key":"10.1016\/j.neo.2026.101378_bib0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1146\/annurev-biochem-061516-044916","article-title":"Mechanisms of deubiquitinase specificity and regulation","volume":"86","author":"Mevissen","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neo.2026.101378_bib0011","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.biochem.78.082307.091526","article-title":"Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes","volume":"78","author":"Reyes-Turcu","year":"2009","journal-title":"Annu. Rev. Biochem."},{"issue":"11","key":"10.1016\/j.neo.2026.101378_bib0012","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1038\/nm.3739","article-title":"Ubiquitination in disease pathogenesis and treatment","volume":"20","author":"Popovic","year":"2014","journal-title":"Nat. Med."},{"issue":"Suppl 1","key":"10.1016\/j.neo.2026.101378_bib0013","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2091-9-S1-S4","article-title":"HPV E6, E6AP and cervical cancer","volume":"9","author":"Beaudenon","year":"2008","journal-title":"BMC. Biochem."},{"issue":"3","key":"10.1016\/j.neo.2026.101378_bib0014","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0092-8674(93)90384-3","article-title":"The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of P53","volume":"75","author":"Scheffner","year":"1993","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.neo.2026.101378_bib0015","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4300\/JGME-D-22-00480.1","article-title":"Narrative reviews: flexible, rigorous, and practical","volume":"14","author":"Sukhera","year":"2022","journal-title":"J. Grad. Med. Educ."},{"key":"10.1016\/j.neo.2026.101378_bib0016","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA-a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res. Integr. Peer. Rev."},{"issue":"2","key":"10.1016\/j.neo.2026.101378_bib0017","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tim.2017.07.007","article-title":"The HPV E6\/E7 oncogenes: key factors for viral carcinogenesis and therapeutic targets","volume":"26","author":"Hoppe-Seyler","year":"2018","journal-title":"Trends. Microbiol."},{"issue":"10","key":"10.1016\/j.neo.2026.101378_bib0018","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.1172\/JCI120518","article-title":"Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis","volume":"128","author":"Su","year":"2018","journal-title":"J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.neo.2026.101378_bib0019","doi-asserted-by":"crossref","DOI":"10.1172\/JCI197926","article-title":"Corrigendum to ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis","volume":"135","author":"Su","year":"2025","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neo.2026.101378_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110351","article-title":"USP7 inhibits TIMP2 by up-regulating the expression of EZH2 to activate the NF-\u03bab\/PD-L1 axis to promote the development of cervical cancer","volume":"96","author":"Li","year":"2022","journal-title":"Cell Signal."},{"issue":"7677","key":"10.1016\/j.neo.2026.101378_bib0021","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature24451","article-title":"Molecular basis of USP7 inhibition by selective small-molecule inhibitors","volume":"550","author":"Turnbull","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neo.2026.101378_bib0022","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.apsb.2020.11.005","article-title":"Abrogation of USP7 is an alternative strategy to downregulate PD-L1 and sensitize gastric cancer cells to T cells killing","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.neo.2026.101378_bib0025","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1158\/1535-7163.MCT-22-0409","article-title":"Ubiquitinated PCNA drives USP1 synthetic lethality in cancer","volume":"22","author":"Simoneau","year":"2023","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.neo.2026.101378_bib0026","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.201800162","article-title":"Specificity for deubiquitination of monoubiquitinated FANCD2 is driven by the N-terminus of USP1","volume":"1","author":"Arkinson","year":"2018","journal-title":"Life Sci. Alliance"},{"issue":"4","key":"10.1016\/j.neo.2026.101378_bib0034","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ncb1378","article-title":"Regulation of monoubiquitinated PCNA by DUB autocleavage","volume":"8","author":"Huang","year":"2006","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.neo.2026.101378_bib0035","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2005.01.008","article-title":"The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway","volume":"17","author":"Nijman","year":"2005","journal-title":"Mol. Cell"},{"issue":"1\u20132","key":"10.1016\/j.neo.2026.101378_bib0036","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.virol.2013.04.013","article-title":"The papillomavirus E7 proteins","volume":"445","author":"Roman","year":"2013","journal-title":"Virology"},{"issue":"7454","key":"10.1016\/j.neo.2026.101378_bib0037","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nature12306","article-title":"CGAS produces a 2\u2032-5\u2032-linked cyclic dinucleotide second messenger that activates STING","volume":"498","author":"Ablasser","year":"2013","journal-title":"Nature"},{"issue":"7668","key":"10.1016\/j.neo.2026.101378_bib0038","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature23449","article-title":"CGAS surveillance of micronuclei links genome instability to innate immunity","volume":"548","author":"Mackenzie","year":"2017","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.neo.2026.101378_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202412687","article-title":"Targeting USP1 potentiates radiation-induced type I IFN-dependent antitumor immunity by enhancing oligo-ubiquitinated SAR1a-mediated STING trafficking and activation","volume":"12","author":"Zhou","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.neo.2026.101378_bib0039","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1146\/annurev.biochem.78.081507.101607","article-title":"Recognition and processing of ubiquitin-protein conjugates by the proteasome","volume":"78","author":"Finley","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neo.2026.101378_bib0040","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.immunol.17.1.739","article-title":"Degradation of cell proteins and the generation of MHC class I-presented peptides","volume":"17","author":"Rock","year":"1999","journal-title":"Annu. Rev. Immunol."},{"issue":"7312","key":"10.1016\/j.neo.2026.101378_bib0041","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nature09299","article-title":"Enhancement of proteasome activity by a small-molecule inhibitor of USP14","volume":"467","author":"Lee","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neo.2026.101378_bib0042","doi-asserted-by":"crossref","first-page":"928","DOI":"10.4049\/jimmunol.1700273","article-title":"Inhibition of the deubiquitinase USP14 diminishes direct MHC class I antigen presentation","volume":"200","author":"Palmer","year":"2018","journal-title":"J. Immunol."},{"issue":"15","key":"10.1016\/j.neo.2026.101378_bib0043","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.7150\/ijbs.47999","article-title":"Iu1 suppresses proliferation of cervical cancer cells through MDM2 degradation","volume":"16","author":"Xu","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.neo.2026.101378_bib0044","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.neo.2026.101378_bib0023","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s00432-024-05710-9","article-title":"USP7 promotes cervical cancer progression by stabilizing MTDH expression through deubiquitination","volume":"150","author":"Wang","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.neo.2026.101378_bib0024","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.immuni.2013.05.018","article-title":"Stabilization of the transcription factor FOXP3 by the deubiquitinase USP7 increases treg-cell-suppressive capacity","volume":"39","author":"van Loosdregt","year":"2013","journal-title":"Immunity"},{"issue":"7812","key":"10.1016\/j.neo.2026.101378_bib0045","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41586-020-2246-4","article-title":"CRISPR screen in regulatory T cells reveals modulators of FOXP3","volume":"582","author":"Cortez","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neo.2026.101378_bib0046","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.2619","article-title":"USP15 stabilizes TGF-\u03b2 receptor I and promotes oncogenesis through the activation of TGF-\u03b2 signaling in glioblastoma","volume":"18","author":"Eichhorn","year":"2012","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.neo.2026.101378_bib0047","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1038\/ncb2346","article-title":"USP15 is a deubiquitylating enzyme for receptor-activated SMADs","volume":"13","author":"Inui","year":"2011","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.neo.2026.101378_bib0048","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s13277-013-1121-4","article-title":"Ubiquitin-specific protease 22: a novel molecular biomarker in cervical cancer prognosis and therapeutics","volume":"35","author":"Yang","year":"2014","journal-title":"Tumour. Biol."},{"issue":"4","key":"10.1016\/j.neo.2026.101378_bib0029","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3892\/or.2014.3354","article-title":"USP22 promotes epithelial-mesenchymal transition via the FAK pathway in pancreatic cancer cells","volume":"32","author":"Ning","year":"2014","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.neo.2026.101378_bib0028","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12964-020-00612-y","article-title":"The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells","volume":"18","author":"Wang","year":"2020","journal-title":"Cell Commun. Signal."},{"issue":"3","key":"10.1016\/j.neo.2026.101378_bib0049","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2326-6066.CIR-19-0661","article-title":"Tumor cell-intrinsic USP22 suppresses antitumor immunity in pancreatic cancer","volume":"8","author":"Li","year":"2020","journal-title":"Cancer Immunol. Res."},{"issue":"7693","key":"10.1016\/j.neo.2026.101378_bib0050","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.neo.2026.101378_bib0051","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019102509","article-title":"The SAGA complex regulates early steps in transcription via its deubiquitylase module subunit USP22","volume":"40","author":"Stanek","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.neo.2026.101378_bib0052","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13644","article-title":"K63-polyubiquitinated HAUSP deubiquitinates HIF-1alpha and dictates H3K56 acetylation promoting hypoxia-induced tumour progression","volume":"7","author":"Wu","year":"2016","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.neo.2026.101378_bib0053","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.it.2012.10.001","article-title":"Indoleamine 2,3 dioxygenase and metabolic control of immune responses","volume":"34","author":"Munn","year":"2013","journal-title":"Trends. Immunol."},{"issue":"21","key":"10.1016\/j.neo.2026.101378_bib0054","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1158\/0008-5472.CAN-12-0569","article-title":"Tryptophan catabolism in cancer: beyond IDO and tryptophan depletion","volume":"72","author":"Platten","year":"2012","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101378_bib0030","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1038\/s41467-022-33285-x","article-title":"USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer","volume":"13","author":"Shi","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neo.2026.101378_bib0031","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12967-025-07442-x","article-title":"Targeting ubiquitin-specific protease 14 reduces metastatic potential and metabolic activity in cervical cancer via direct modulation of monocarboxylate transporter-4","volume":"24","author":"Chauhan","year":"2026","journal-title":"J. Transl. Med."},{"issue":"7","key":"10.1016\/j.neo.2026.101378_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2023.05.015","article-title":"MCT4-dependent lactate secretion suppresses antitumor immunity in LKB1-deficient lung adenocarcinoma","volume":"41","author":"Qian","year":"2023","journal-title":"Cancer Cell"},{"issue":"6881","key":"10.1016\/j.neo.2026.101378_bib0056","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature737","article-title":"Deubiquitination of P53 by HAUSP is an important pathway for P53 stabilization","volume":"416","author":"Li","year":"2002","journal-title":"Nature"},{"issue":"5827","key":"10.1016\/j.neo.2026.101378_bib0057","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1141478","article-title":"MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling","volume":"316","author":"Engelman","year":"2007","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.neo.2026.101378_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109593","article-title":"Type I interferon regulation by USP18 is a key vulnerability in cancer","volume":"27","author":"Jov\u00e9","year":"2024","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.neo.2026.101378_bib0059","doi-asserted-by":"crossref","first-page":"5324","DOI":"10.1038\/s41598-020-62076-x","article-title":"Selective USP7 inhibition elicits cancer cell killing through a P53-dependent mechanism","volume":"10","author":"Schauer","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.neo.2026.101378_bib0060","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1158\/1535-7163.MCT-24-0515","article-title":"Characterization of TNG348: a selective, allosteric USP1 inhibitor that synergizes with PARP inhibitors in tumors with homologous recombination deficiency","volume":"24","author":"Simoneau","year":"2025","journal-title":"Mol. Cancer Ther."},{"issue":"3","key":"10.1016\/j.neo.2026.101378_bib0061","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ccr.2012.08.007","article-title":"A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance","volume":"22","author":"Chauhan","year":"2012","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.neo.2026.101378_bib0062","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.400","article-title":"USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing P53-mediated apoptosis","volume":"4","author":"Fan","year":"2013","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.neo.2026.101378_bib0063","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116071","article-title":"Identification of YCH2823 as a novel USP7 inhibitor for cancer therapy","volume":"222","author":"Cheng","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.neo.2026.101378_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2017.09.010","article-title":"Lessons in PROTAC design from selective degradation with a promiscuous warhead","volume":"25","author":"Bondeson","year":"2018","journal-title":"Cell Chem. Biol."},{"issue":"4","key":"10.1016\/j.neo.2026.101378_bib0068","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/s41589-022-00971-2","article-title":"Deubiquitinase-targeting chimeras for targeted protein stabilization","volume":"18","author":"Henning","year":"2022","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.neo.2026.101378_bib0069","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202415168","article-title":"The first-in-class deubiquitinase-targeting chimera stabilizes and activates cGAS","volume":"64","author":"Deng","year":"2025","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"16","key":"10.1016\/j.neo.2026.101378_bib0070","doi-asserted-by":"crossref","first-page":"13754","DOI":"10.1021\/jacs.5c01889","article-title":"USP28-based deubiquitinase-targeting chimeras for cancer treatment","volume":"147","author":"Wang","year":"2025","journal-title":"J. Am. Chem. Soc."},{"issue":"6","key":"10.1016\/j.neo.2026.101378_bib0075","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/2159-8290.CD-18-1218","article-title":"PARP inhibitor efficacy depends on CD8(+) T-cell recruitment via intratumoral STING pathway activation in BRCA-deficient models of triple-negative breast cancer","volume":"9","author":"Pantelidou","year":"2019","journal-title":"Cancer Discov."},{"issue":"16_suppl","key":"10.1016\/j.neo.2026.101378_bib0072","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1200\/JCO.2024.42.16_suppl.3005","volume":"42","author":"Yap","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.neo.2026.101378_bib0074","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s10637-020-00915-4","article-title":"Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and\/or refractory multiple myeloma","volume":"38","author":"Rowinsky","year":"2020","journal-title":"Invest. New Drugs"},{"issue":"8","key":"10.1016\/j.neo.2026.101378_bib0077","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.4049\/jimmunol.1403165","article-title":"USP9x is required for lymphocyte activation and homeostasis through its control of ZAP70 ubiquitination and pkc\u03b2 kinase activity","volume":"196","author":"Naik","year":"2016","journal-title":"J. Immunol."},{"issue":"23","key":"10.1016\/j.neo.2026.101378_bib0078","doi-asserted-by":"crossref","first-page":"9433","DOI":"10.1073\/pnas.1221925110","article-title":"Regulation of T cell function by the ubiquitin-specific protease USP9x via modulating the Carma1-bcl10-malt1 complex","volume":"110","author":"Park","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U S. A"},{"issue":"9","key":"10.1016\/j.neo.2026.101378_bib0079","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.4049\/jimmunol.1401451","article-title":"Cutting edge: ubiquitin-specific protease 4 promotes Th17 cell function under inflammation by deubiquitinating and stabilizing ror\u03b3t","volume":"194","author":"Yang","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.neo.2026.101378_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216836","article-title":"Deubiquitinase USP4 suppresses antitumor immunity by inhibiting IRF3 activation and tumor cell-intrinsic interferon response in colorectal cancer","volume":"589","author":"Zhou","year":"2024","journal-title":"Cancer Lett."},{"issue":"7645","key":"10.1016\/j.neo.2026.101378_bib0081","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature21386","article-title":"The cancer genome atlas research network, integrated genomic and molecular characterization of cervical cancer","volume":"543","year":"2017","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.neo.2026.101378_bib0082","doi-asserted-by":"crossref","first-page":"13375","DOI":"10.18632\/oncotarget.14533","article-title":"Identification and characterization of HPV-independent cervical cancers","volume":"8","author":"Banister","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.neo.2026.101378_bib0083","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/clpt.2009.68","article-title":"I-SPY 2: an adaptive breast cancer trial design in the setting of neoadjuvant chemotherapy","volume":"86","author":"Barker","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neo.2026.101378_bib0084","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104846","article-title":"Single-nucleus RNA sequencing reveals heterogenous microenvironments and specific drug response between cervical squamous cell carcinoma and adenocarcinoma","volume":"97","author":"Lin","year":"2023","journal-title":"EBioMedicine"},{"issue":"29","key":"10.1016\/j.neo.2026.101378_bib0085","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202203040","article-title":"Single-nucleus RNA sequencing and spatial transcriptomics reveal the immunological microenvironment of cervical squamous cell carcinoma","volume":"9","author":"Ou","year":"2022","journal-title":"Adv. Sci."},{"issue":"7718","key":"10.1016\/j.neo.2026.101378_bib0086","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neo.2026.101378_bib0087","article-title":"The role of the metabolic parameters of (18)F-FDG PET\/CT in patients with locally advanced cervical cancer, front","volume":"11","author":"Wang","year":"2021","journal-title":"Oncology"},{"issue":"9","key":"10.1016\/j.neo.2026.101378_bib0088","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.chembiol.2014.09.001","article-title":"Small-molecule inhibitors of protein-protein interactions: progressing toward the reality","volume":"21","author":"Arkin","year":"2014","journal-title":"Chem. Biol."},{"issue":"11","key":"10.1016\/j.neo.2026.101378_bib0089","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/sj.emboj.7601149","article-title":"UBP43 is a novel regulator of interferon signaling independent of its ISG15 isopeptidase activity","volume":"25","author":"Malakhova","year":"2006","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.neo.2026.101378_bib0090","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMra1510062","article-title":"Master protocols to study multiple therapies, multiple diseases, or both","volume":"377","author":"Woodcock","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.neo.2026.101378_bib0091","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cell.2020.03.023","article-title":"CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors","volume":"181","author":"Wang","year":"2020","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.neo.2026.101378_bib0032","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1158\/0008-5472.CAN-22-1812","article-title":"USP48 stabilizes gasdermin E to promote pyroptosis in cancer","volume":"83","author":"Ren","year":"2023","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101378_bib0033","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41420-025-02883-1","article-title":"USP25 attenuates the immunosuppressive tumor microenvironment via the deubiquitination of TAB2 in head and neck squamous cell carcinoma","volume":"12","author":"Li","year":"2026","journal-title":"Cell Death. Discov."},{"issue":"20","key":"10.1016\/j.neo.2026.101378_bib0071","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.1158\/0008-5472.CAN-24-0293","article-title":"The USP1 inhibitor KSQ-4279 overcomes PARP inhibitor resistance in homologous recombination-deficient tumors","volume":"84","author":"Cadzow","year":"2024","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.neo.2026.101378_bib0073","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/s41422-018-0091-x","article-title":"Small molecule inhibitors reveal allosteric regulation of USP14 via steric blockade","volume":"28","author":"Wang","year":"2018","journal-title":"Cell Res."}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626001107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626001107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T16:18:01Z","timestamp":1793636281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626001107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":87,"alternative-id":["S1476558626001107"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101378","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ubiquitin-specific proteases and the immune microenvironment in cervical cancer: mechanistic evidence, immunotherapy resistance, and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101378"}}